ReviewTranslational cancer research2020
Treatment and patient related quality of life issues in elderly and very elderly breast cancer patients.
Review in Translational cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 17 citations in OpenAlex.
- Impact of radiotherapy on quality of life reported by elderly patients.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- An Interdisciplinary Ecosystem for the Prevention of Cardiotoxicity in Older Patients With Breast Cancer: Protocol for a Prospective and Multicentric Study.JMIR research protocols · 2025Article
- Early death prediction model for breast cancer with synchronous lung metastases: an analysis of the SEER database.Gland surgery · 2024Article
- The increasing prevalence of cancer in the elderly: An investigation of epidemiological trends.Aging medicine (Milton (N.S.W)) · 2024Review
- Multicenter Study on Breast Cancer in the Geriatric Population: Insights for Effective Treatment Strategies.Cureus · 2024Article
- Benefits and Harms of Mammography Screening in 75 + Women to Inform Shared Decision-making: a Simulation Modeling Study.Journal of general internal medicine · 2024Article
- The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions.Journal of clinical medicine · 2023Review
- Article
- Dexmetomidine promotes the activity of breast cancer cells through miR-199a/HIF-1α axis.Translational cancer research · 2021Article
- A narrative review of risk factors and interventions for cancer-related cognitive impairment.Annals of translational medicine · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the number of aging population increases, a significant amount of elderly cancer patients need more personalized care for their cancer treatment. Breast cancer is the most common cancer in women, and almost half of the newly diagnosed patients are older than the age of 65 years. With their peculiar characteristics, elderly patients with breast cancer should be held with a comprehensive geriatric assessment. It is vital to make the choice of correct treatment more delicately, to better predict the prognosis of the patient and risks associated with specific treatments. The current article focuses on how various methods of treatment in elderly breast cancer affect their quality of life and the challenges they experience among age from 70 to 79 and age from 80 and over subgroups of this population. Treatment (surgery, radiation therapy, chemotherapy, and endocrine therapy) and patient-related (mental health, physical function, frailty, cognitive function, nutrition) quality of life issues are revisited in the light of recent literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.